Simplex Trading’s Palvella Therapeutics PVLA Stock Holding History

Simplex Trading’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-300	Closed	-$37.4K	–	10561
2026 Q1	$37.4K	Buy	+300	New	+$31.3K	﹤0.01%	6166
2025 Q2	–	Sell	-100	Closed	-$2K	–	9966
2025 Q1	$2K	Buy	+100	New	+$1.93K	﹤0.01%	8119
2023 Q1	–	Sell	-21	Closed	-$1K	–	10338
2022 Q4	$1K	Hold	21	–	–	﹤0.01%	8970
2022 Q3	$1K	Sell	21 -14	-40%	-$1.8K	﹤0.01%	9692
2022 Q2	$5K	Sell	35 -4	-10%	-$730	﹤0.01%	8882
2022 Q1	$9K	Sell	39 -22	-36%	-$5.78K	﹤0.01%	8997
2021 Q4	$18K	Sell	61 -409	-87%	-$131K	﹤0.01%	8505
2021 Q3	$145K	Buy	470 +1	+0.2%	+$348	﹤0.01%	6092
2021 Q2	$143K	Buy	+469	New	+$103K	﹤0.01%	6211
2020 Q4	–	Hold	0	–	-$6K	–	9218
2020 Q3	–	Hold	0	–	–	–	7063
2019 Q4	–	Sell	-1	Closed	-$37K	–	8093
2019 Q3	$37K	Buy	+1	New	+$387	﹤0.01%	5312

Other funds holding PVLA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Simplex Trading's PVLA Position: Q2 2026 in Review

Simplex Trading increased its Palvella Therapeutics (PVLA) stake by 37% in Q2 2026, buying an estimated $72.3K and bringing the position to 2,218 shares worth $339K. The position accounts for ﹤0.01% of the portfolio, ranked #4085.

Simplex Trading first reported a position in PVLA in Q1 2018 and has held it in 13 quarters since. 197 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Simplex Trading held 2,218 shares of Palvella Therapeutics worth $339K as of Q2 2026.
Simplex Trading bought 596 Palvella Therapeutics shares in Q2 2026, an estimated $72.3K.
Palvella Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #4085 holding.
Simplex Trading first reported a position in Palvella Therapeutics in Q1 2018 and has held it in 13 quarters since.
197 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.